Psychometric Evaluation of the Hypoparathyroidism Symptom Diary: Data from a Prospective Phase 3b/4 Study
Patient Related Outcome Measures · 31.12.2026 · 16 · 285-308
DOI: 10.2147/prom.s539994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Patient Related Outcome Measures, online erschienen am 09.03.2026. Verfasst von Suwei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Development Center Americas Inc., Lexington, MA, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Development Center Americas Inc., Lexington, MA, USA.
Abstract (Originalsprache)
Purpose
To assess the psychometric properties of the disease-specific Hypoparathyroidism Symptom Diary (HypoPT-SD) patient-reported outcome (PRO) tool, which consists of a 7-item symptom subscale, a 4-item impact subscale, a single item for anxiety, and a single item for sadness or depression, using data from the BALANCE randomized, placebo-controlled Phase 3b/4 study (NCT03324880).
Methods
Eligible patients had symptomatic hypoparathyroidism (HypoPT) at baseline and were aged 18-85 years (inclusive). Patients received recombinant human parathyroid hormone (1-84) or placebo. The HypoPT-SD was filled in daily; data recorded at baseline and Weeks 4, 12, and 26 (end of treatment [EOT]) were included in this analysis. Inter-item and item-total correlations were used to assess HypoPT-SD structure; Cronbach's coefficient α was used to analyze the internal consistency and reliability, and intraclass correlations were used to measure test-retest reliability. Construct validity was determined using correlational analyses between HypoPT-SD scores and scores from other conceptually similar PRO tools. Ability to detect change was assessed and thresholds for meaningful within-patient change were established.
Results
The psychometric analysis population (N=93) was predominantly female (88.2%) and white (96.8%), with a mean age of 48.5 years. Inter-item correlations ranged from 0.35 to 0.85 at baseline and from 0.49 to 0.93 at EOT. Item-total correlations ranged from 0.57 to 0.83 at baseline and from 0.69 to 0.88 at EOT. Cronbach's α values at baseline were 0.90 (symptom subscale) and 0.88 (impact subscale). Intraclass correlation coefficients for both subscales in stable patients exceeded 0.70. Significant cross-sectional correlations were observed with most of the conceptually linked PRO tools analyzed, and HypoPT-SD scores were responsive to change. Potential changes of 1.5 (symptom subscale) and 0.8 (impact subscale) were determined as meaningful change thresholds for within-patient improvements.
Conclusion
The HypoPT-SD is a reliable measure of key symptoms and impacts of HypoPT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Takeda Development Center Americas Inc., Lexington, MA, USA.
- RTI Health Solutions, Research Triangle Park, Durham, NC, USA.
ORCID-Profile: Nicholas J Rockwood, Olulade Ayodele
Förderung
- Takeda Development Center Americas Inc., Lexington, MA, USA
Zitieren
APA
Wang, S., Rockwood, N. J., Yarr, S., Korver, D., Castriota, F., Martin, S., & Ayodele, O. (2026). Psychometric Evaluation of the Hypoparathyroidism Symptom Diary: Data from a Prospective Phase 3b/4 Study. Patient Related Outcome Measures, 16(0), 285-308. https://doi.org/10.2147/prom.s539994
Vancouver
Wang S, Rockwood NJ, Yarr S, Korver D, Castriota F, Martin S, et al. Psychometric Evaluation of the Hypoparathyroidism Symptom Diary: Data from a Prospective Phase 3b/4 Study. Patient Related Outcome Measures. 2026;16(0):285-308. doi:10.2147/prom.s539994
BibTeX
@article{Wang2026,
author = {Wang, Suwei and Rockwood, Nicholas J and Yarr, Stuart and Korver, Dane and Castriota, Felicia and Martin, Susan and Ayodele, Olulade},
title = {Psychometric Evaluation of the Hypoparathyroidism Symptom Diary: Data from a Prospective Phase 3b/4 Study},
journal = {Patient Related Outcome Measures},
year = {2026},
volume = {16},
number = {0},
pages = {285--308},
doi = {10.2147/prom.s539994}
}
EUVIMED